LyondellBasell Industries N.V. Q2 FY26 Results — Earnings Call Analysis

Published 29 May 2026 | Chemicals | Market Cap: ₹22.1K Cr

- Technology segment expects improved results in Q2 due to licensing milestones and shipment timing. - Future growth projects (e.g., MoReTec-1) expected to ramp up by end of 2027, adding ~$400 million EBITDA.

From LyondellBasell Industries N.V.'s Q2 FY26 earnings-call transcript · updated 29 May 2026.

Price

68.35

Market Cap

₹22.1K Cr

P/E Ratio

9.1

Revenue Rank

Rank 3

Margin Rank

Rank 3

How does LyondellBasell Industries N.V. rank in Chemicals?

Compare LyondellBasell Industries N.V. against every Chemicals company this quarter on revenue, margins and earnings-call signals.

Revenue: Rank 3Margin: Rank 3
View Chemicals leaderboard →

📊 Revenue & Sales Performance

Rank 3
  • Technology segment expects improved results in Q2 due to licensing milestones and shipment timing.
  • Polymer margins and volumes are improving; operating rates to increase to ~80% across the segment in Q2.
  • Advanced Polymer Solutions (APS) segment is seeing volume increases driven by seasonal demand and customer focus, though margins face raw material cost pressures.
  • Intermediates and Derivatives segment targeting ~75% operating rates in Q2, expecting improved volumes and margins from seasonal recovery and restarts.
  • Polypropylene business anticipated to turn positive with increased operating rates (70-75% current to higher) and tightening global supply due to Strait of Hormuz impact.
  • Long-term growth projects (e.g., MoReTec-1 expected ramp-up end of 2027) aim to add ~$400 million EBITDA.
  • Overall, supply disruptions and regional dynamics are supporting better pricing and demand, with cautious optimism for volume and revenue growth over 2-4 years.

📈 Profitability & Margins

Rank 3
  • Future growth projects (e.g., MoReTec-1) expected to ramp up by end of 2027, adding ~$400 million EBITDA.
  • Higher second-quarter margins and volumes anticipated due to global supply tightness and strong order books.
  • Operating rates targeted around 75% (I&D segment) to 90% (O&P Americas segment) in Q2.
  • Passing through higher raw material and energy costs expected while maintaining profitability.
  • Improved Technology segment results forecasted in Q2 due to shipment timing and licensing milestones.
  • European portfolio transformation and asset sale to reduce fixed costs (~EUR 400 million annually) and improve mid-cycle EBITDA margins to 21%+.
  • Capital allocation focus remains on investment-grade balance sheet, safe operations, and cash improvement plan.
  • Cautious near-term demand outlook in automotive and durable goods but packaging demand remains robust; no current evidence of demand destruction.

🏗️ Capital Expenditure Plans

Yes
  • Modest investments planned in Hyperzone reliability and acetyls debottlenecks to deliver incremental value.
  • Construction on MoReTec-1 continues as planned with ramp-up expected toward end of 2027, projected to increase EBITDA by ~$400 million.
  • Near-term focus remains on investing in safe and reliable operations.
  • Capital allocation priorities emphasize disciplined capital spending and balance sheet strength.
  • Several attractive projects ready for investment, but will proceed only when balance sheet and outlook are more secure.
  • Sale of 4 European assets completed to sharpen capital allocation focus on strategic assets for long-term value creation.
  • Continued emphasis on MoReTec investments and polypropylene joint venture expansion in Saudi Arabia (second phase to double capacity).

💰 Fundraising & Capital Structure

No information
  • No new fundraising through debt or equity was announced in the call.
  • The company focused on protecting its investment-grade balance sheet and improving financial flexibility.
  • Actions include a 50% reduction in the quarterly dividend to rebalance capital allocation.
  • LYB plans to repay 2026 and 2027 debt maturities that were prefunded in 2025.
  • The company will only proceed with new investments when the balance sheet and outlook are more secure.
  • The emphasis remains on capital discipline and cash improvement rather than raising new funds.

📋 Order Book & Pipeline

No
  • Licensing activity declined in Q1 due to slower global polyolefins capacity growth and lower catalyst sales tied to shipping constraints from the Middle East war.
  • Q2 expected to see improved Technology segment results as milestone shipments and licensing revenues increase.
  • Demand is at historically low levels, with some projects in "reserved status," delaying investments over the next 2-4 years.
  • Overall, orderbook/pending orders in licensing are lagging currently but anticipated to improve in Q2.
  • The delayed investments due to low licensing volumes in recent years mean fewer new projects will come online short term.
  • The company projects second quarter licensing to be better than Q1 but still facing headwinds due to geopolitical impacts.

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No

Others in Chemicals this season

  • Westlake Corporation (Q2 FY26)

    Westlake Corporation Q2 FY26 quarterly results analysis. HIP segment volume growth driven by strong infrastructure spending and data center cooling needs, suppo

  • RPM International Inc. (Q2 FY26)

    RPM International Inc. Q2 FY26 quarterly results analysis. RPM expects mid-single-digit revenue growth in Q4 fiscal ’26, aided by M&A (Page 4). Market Cap $13,6

  • Solstice Advanced Materials, Inc. (Q2 FY26)

    Solstice Advanced Materials, Inc. Q2 FY26 quarterly results analysis. Strong momentum heading into Q2 with 5 planned maintenance outages on track (Page 9). Mark

  • International Flavors & Fragrances Inc. (Q2 FY26)

    International Flavors & Fragrances Inc. Q2 FY26 quarterly results analysis. The company expects solid top-line growth driven by volume growth across all segment

Frequently Asked Questions

What were LyondellBasell Industries N.V. Q2 FY26 results?

- Technology segment expects improved results in Q2 due to licensing milestones and shipment timing. - Future growth projects (e.g., MoReTec-1) expected to ramp up by end of 2027, adding ~$400 million EBITDA.

What is LyondellBasell Industries N.V. share price analysis?

LyondellBasell Industries N.V. currently shows a below-average growth signal. The stock trades at a P/E of 9.1 with a market cap of $22,062. Investors should review the full earnings analysis for detailed insights.

Is LyondellBasell Industries N.V. planning capital expenditure?

- Modest investments planned in Hyperzone reliability and acetyls debottlenecks to deliver incremental value.

Keep LyondellBasell Industries N.V. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.